Instituto Brasileiro de Osteopatia Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2012
NCT02974166
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Instituto Brasileiro de Osteopatia

Active Ingredients

Drugs in Other Trials (2)

cyclobenzaprine (flexeril) (1 trial)

ibuprofen (motrin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2